Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lana A Castellucci

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Thrombosis Research|June 22, 2019
It's time for head-to-head trials with direct oral anticoagulantsTobias Tritschler, Lana A Castellucci
Journal of Thrombosis and Haemostasis : JTH|October 14, 2024
Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and ThrombosisLana A Castellucci, Louise St Germain
BMJ Case Reports|May 17, 2019
A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditisHart A Goldhar, Paloma O'Meara, Lana A Castellucci
BMJ (Clinical Research Ed.)|August 8, 2020
Pulmonary embolism: update on management and controversiesLisa Duffett, Lana A Castellucci, Melissa A Forgie
JAMA|January 28, 2015
Nonleg venous thrombosis in critically ill adultsLana A Castellucci, Philip S Wells, Lisa Duffett
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. ReplyLana A Castellucci, Gregoire Le Gal, Marc Rodger, et al.
CJEM|February 6, 2025
Just the facts: diagnosis and management of superficial thrombophlebitis in the EDSamara Adler, Lana A Castellucci, Warren J Cheung
Hamostaseologie|July 30, 2020
Management of Anticoagulant Treatment and Anticoagulation-Related Complications in NonagenariansMichela Giustozzi, Lana A Castellucci, Geoffrey D Barnes
The Medical Clinics of North America|June 11, 2025
Thrombophilia Testing in Venous ThromboembolismKristina Vrotniakaite-Bajerciene, Anne Angelillo-Scherrer, Lana A Castellucci
Thrombosis Research|July 20, 2014
Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarinAbirami Vijenthira, Gregoire Le Gal, Lana A Castellucci, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Thrombosis Research|June 22, 2019
It's time for head-to-head trials with direct oral anticoagulantsTobias Tritschler, Lana A Castellucci
Journal of Thrombosis and Haemostasis : JTH|October 14, 2024
Recognizing the 11th Year of World Thrombosis Day: A Call to Action for Health Care Professionals with a Focus on Women and ThrombosisLana A Castellucci, Louise St Germain
BMJ Case Reports|May 17, 2019
A case of antiphospholipid syndrome presenting cryptogenically as Budd-Chiari syndrome, then fulminantly as Libman-Sacks endocarditisHart A Goldhar, Paloma O'Meara, Lana A Castellucci
BMJ (Clinical Research Ed.)|August 8, 2020
Pulmonary embolism: update on management and controversiesLisa Duffett, Lana A Castellucci, Melissa A Forgie
JAMA|January 28, 2015
Nonleg venous thrombosis in critically ill adultsLana A Castellucci, Philip S Wells, Lisa Duffett
The New England Journal of Medicine|June 10, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. ReplyLana A Castellucci, Gregoire Le Gal, Marc Rodger, et al.
CJEM|February 6, 2025
Just the facts: diagnosis and management of superficial thrombophlebitis in the EDSamara Adler, Lana A Castellucci, Warren J Cheung
Hamostaseologie|July 30, 2020
Management of Anticoagulant Treatment and Anticoagulation-Related Complications in NonagenariansMichela Giustozzi, Lana A Castellucci, Geoffrey D Barnes
The Medical Clinics of North America|June 11, 2025
Thrombophilia Testing in Venous ThromboembolismKristina Vrotniakaite-Bajerciene, Anne Angelillo-Scherrer, Lana A Castellucci
Thrombosis Research|July 20, 2014
Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarinAbirami Vijenthira, Gregoire Le Gal, Lana A Castellucci, et al.
Pageof 7